HPIV2 vaccine

The HPIV2 vaccine is a candidate or investigational immunization designed to protect against infection by human parainfluenza virus type 2 (HPIV-2), a common cause of respiratory illnesses such as croup, bronchiolitis, and pneumonia in children. The mechanism of action involves stimulating the immune system to produce antibodies and cellular responses that target HPIV-2, thereby preventing infection or reducing disease severity upon exposure. As of now, there is no licensed or widely available commercial HPIV-2 vaccine; most efforts are in preclinical or early clinical development stages. The primary indication would be prevention of respiratory tract infections caused by HPIV-2.

Other names

human parainfluenza virus type 2 vaccineparainfluenza type 2 vaccine